Expression of ErbB receptors and their cognate ligands in gastric and colon cancer cell lines.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Anticancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 19331154
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of HB-EGF and amphiregulin as targets for human cancer therapy.

  2008cited by this paper
• Cetuximab for the treatment of colorectal cancer.

  2007cited by this paper
• An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).

  2007cited by this paper
• Human Breast Cancer Cells Selected for Resistance to Trastuzumab In vivo Overexpress Epidermal Growth Factor Receptor and ErbB Ligands and Remain Dependent on the ErbB Receptor Network

  2007cited by this paper
• Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

  2007cited by this paper
• EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms.

  2006cited by this paper
• The developing role of receptors and adaptors

  2006cited by this paper
• Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis

  2006cited by this paper
• Targeting ADAMS and ERBBs in lung cancer.

  2006cited by this paper
• ErbB receptors: new insights on mechanisms and biology.

  2006cited by this paper
• Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors

  2006cited by this paper
• ERBB receptors and cancer: the complexity of targeted inhibitors

  2005cited by this paper
• ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors

  2005cited by this paper
• Critical update and emerging trends in epidermal growth factor receptor targeting in cancer.

  2005cited by this paper
• Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

  2004cited by this paper
• Cetuximab in the treatment of colorectal cancer.

  2004cited by this paper
• Blockade of Epidermal Growth Factor- or Heregulin-Dependent ErbB2 Activation with the Anti-ErbB2 Monoclonal Antibody 2C4 Has Divergent Downstream Signaling and Growth Effects

  2004cited by this paper
• Neuroglycan C, a novel member of the neuregulin family.

  2004cited by this paper
• Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.

  2003cited by this paper
• Epidermal Growth Factor Receptor-stimulated Activation of Phospholipase Cγ-1 Promotes Invasion of Head and Neck Squamous Cell Carcinoma

  2003cited by this paper
• Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage.

  2003cited by this paper
• Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth.

  2001cited by this paper
• Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells.

  2000cited by this paper
• Estimates of the worldwide mortality from 25 cancers in 1990

  1999cited by this paper
• Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells.

  1999cited by this paper
• Expression of heregulin α, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells

  1999cited by this paper
• The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer.

  1997cited by this paper
• In vitro activation of Stat3 by epidermal growth factor receptor kinase.

  1996cited by this paper
• Requirement for phosphatidylinositol transfer protein in epidermal growth factor signaling.

  1995cited by this paper
• Neuroglycan C, a Novel Membrane-spanning Chondroitin Sulfate Proteoglycan That Is Restricted to the Brain (*)

  1995cited by this paper
• Autonomous proliferation of colon cancer cells that coexpress transforming growth factor alpha and its receptor. Variable effects of receptor-blocking antibody.

  1992cited by this paper

• Clinical Significance of EREG Gene Expression in Gastric Cancer Tissue After Curative Surgery

  2022cites this paper
• Serum biomarker panels for the diagnosis of gastric cancer

  2019cites this paper
• Elevated epiregulin expression predicts poor prognosis in gastric cancer.

  2019cites this paper
• Current Challenges and Opportunities in Treating Glioblastoma

  2018cites this paper
• Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients

  2018cites this paper
• Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients

  2018cites this paper
• Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer

  2018cites this paper
• Tumor endothelial cells promote metastasis and cancer stem cell-like phenotype through elevated Epiregulin in esophageal cancer.

  2016cites this paper
• Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues.

  2015cites this paper
• Generation and Activity of a Humanized Monoclonal Antibody That Selectively Neutralizes the Epidermal Growth Factor Receptor Ligands Transforming Growth Factor-α and Epiregulin

  2014influential citation
• Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage.

  2014cites this paper
• Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer

  2014cites this paper
• Generation and Activity of a Humanized Monoclonal Antibody that Selectively Neutralizes the Epidermal Growth Factor Receptor Ligands TGF-alpha and Epiregulin

  2014influential citation
• Expression of the EGF Family in Gastric Cancer: Downregulation of HER4 and Its Activating Ligand NRG4

  2014cites this paper
• Epiregulin: roles in normal physiology and cancer.

  2014cites this paper
• Identifying Determinants of EGFR-Targeted Therapeutic Biochemical Efficacy Using Computational Modeling

  2014cites this paper
• Simultaneous Profiling of 194 Distinct Receptor Transcripts in Human Cells

  2013cites this paper
• Peptides dérivés de cd44v6 pour le traitement de cancers du sein

  2013cites this paper
• Receptors and ligands role in colon physiology and pathology

  2013cites this paper
• Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo.

  2013cites this paper
• EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo.

  2013cites this paper
• Advances in analysis of novel protein therapeutics and clinical samples with LC-MS/MS methods

  2013cites this paper
• Regulation of EGF receptor dynamics by protein tyrosine phosphatases

  2013cites this paper
• The expression and localization of neuregulin-1 (Nrg1) in the gastrointestinal system of the rhesus monkey.

  2013cites this paper
• Two initiation sites of early detection of colon cancer revealed by localization of pERK1/2 in the nuclei or in aggregates at the perinuclear region of the tumor cells.

  2013cites this paper
• Anatomical, biochemical and physiological considerations of the colon in design and development of novel drug delivery systems.

  2012cites this paper
• Metastatic gastric cancer – focus on targeted therapies

  2012cites this paper
• Single Molecule Fluorescence Detection and Tracking in Mammalian Cells: The State-of-the-Art and Future Perspectives

  2012cites this paper
• An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling

  2012cites this paper
• The ligand-specific co-receptor function of CD44 for receptor tyrosine kinases

  2012cites this paper
• Two initiation sites of early detection of colon cancer, revealed by localization of pERK1/2 in the nuclei or in aggregates at the perinuclear region of tumor cells.

  2011cites this paper
• TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival.

  2011cites this paper
• Targeting the human EGFR family in esophagogastric cancer

  2011cites this paper
• Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis.

  2010cites this paper